T 0079/01 (Urinary tumor/CANCERVAX) of 25.3.2003

European Case Law Identifier: ECLI:EP:BA:2003:T007901.20030325
Date of decision: 25 March 2003
Case number: T 0079/01
Application number: 90917644.8
IPC class: G01N 33/574
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 58 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Urinary tumor associated antigen, antigenic subunits uses and methods of detection
Applicant name: Cancervax, Corp.
Opponent name: Boehringer Ingelheim GmbH
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 108
European Patent Convention 1973 R 65(1)
RFees Art 9
Keywords: Appeal admissible - (no)
Less than half of the appeal fee paid
Catchwords:

-

Cited decisions:
G 0008/91
G 0009/91
G 0002/97
G 0001/99
T 0152/82
T 0017/83
T 0170/83
T 0173/89
T 0690/93
T 1072/93
T 0253/95
T 0923/95
Citing decisions:
G 0001/18
T 1265/10
T 2017/12
T 1553/13
T 1897/17

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010079eu1.html

Date retrieved: 17 May 2021

21 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Offical Journal of the EPO

Case Law Book: V Priority

Case Law of the Enlarged Board

General Case Law